FR2297635A1 - Vaccin antigrippal contenant un antigene neuraminidase purifie et application - Google Patents

Vaccin antigrippal contenant un antigene neuraminidase purifie et application

Info

Publication number
FR2297635A1
FR2297635A1 FR7600974A FR7600974A FR2297635A1 FR 2297635 A1 FR2297635 A1 FR 2297635A1 FR 7600974 A FR7600974 A FR 7600974A FR 7600974 A FR7600974 A FR 7600974A FR 2297635 A1 FR2297635 A1 FR 2297635A1
Authority
FR
France
Prior art keywords
application
influenza vaccine
vaccine containing
neuraminidase antigen
purified neuraminidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7600974A
Other languages
English (en)
French (fr)
Other versions
FR2297635B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/541,512 external-priority patent/US4029763A/en
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of FR2297635A1 publication Critical patent/FR2297635A1/fr
Application granted granted Critical
Publication of FR2297635B1 publication Critical patent/FR2297635B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7600974A 1975-01-16 1976-01-15 Vaccin antigrippal contenant un antigene neuraminidase purifie et application Granted FR2297635A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/541,512 US4029763A (en) 1974-08-05 1975-01-16 Influenza vaccine containing purified neuraminidase antigen and method of using the same

Publications (2)

Publication Number Publication Date
FR2297635A1 true FR2297635A1 (fr) 1976-08-13
FR2297635B1 FR2297635B1 (enrdf_load_stackoverflow) 1980-06-27

Family

ID=24159889

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600974A Granted FR2297635A1 (fr) 1975-01-16 1976-01-15 Vaccin antigrippal contenant un antigene neuraminidase purifie et application

Country Status (7)

Country Link
AU (1) AU507149B2 (enrdf_load_stackoverflow)
BE (1) BE837603A (enrdf_load_stackoverflow)
CA (1) CA1073355A (enrdf_load_stackoverflow)
FR (1) FR2297635A1 (enrdf_load_stackoverflow)
GB (1) GB1536475A (enrdf_load_stackoverflow)
NL (1) NL7600443A (enrdf_load_stackoverflow)
PH (1) PH13837A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041880A1 (fr) * 1980-06-05 1981-12-16 Synthelabo Procédé pour isoler des antigènes glycoprotéiques viraux et son application à la préparation de vaccins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041880A1 (fr) * 1980-06-05 1981-12-16 Synthelabo Procédé pour isoler des antigènes glycoprotéiques viraux et son application à la préparation de vaccins

Also Published As

Publication number Publication date
FR2297635B1 (enrdf_load_stackoverflow) 1980-06-27
AU507149B2 (en) 1980-02-07
CA1073355A (en) 1980-03-11
PH13837A (en) 1980-10-16
BE837603A (fr) 1976-05-03
AU1016376A (en) 1977-07-14
NL7600443A (nl) 1976-07-20
GB1536475A (en) 1978-12-20

Similar Documents

Publication Publication Date Title
RO73466A (ro) Dispozitiv pentru inhalarea medicamentelor
FR2620941B1 (fr) Vaccin contenant des adjuvants et des antigenes tumoraux
IT1050262B (it) Compizione per restauro dentario opaca ai raggi os e translucida
FR2499412B1 (fr) Production de vaccin antivirus
IT1059765B (it) Dispositivo per la depurazione di gas
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE863676A (fr) Vaccin syncytial du virus respiratoires
NL7702784A (nl) Werkwijze voor het zuiveren en isoleren van he- patitisvirus ten gebruike bij de bereiding van een vaccin.
FR2307525A1 (fr) Analogues acetyleniques de prostaglandines et medicaments qui en contiennent
SE7604818L (sv) Vaccin
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE827572A (fr) Vaccin a base de cytomegalovirus fortement attenues et sa production
BE843368A (fr) Conditionnement de clous en chapelet
FR2321898A1 (fr) Medicament contenant un poly-(amino-acide)
SE7800781L (sv) Nytt vaccin
FR2303568A1 (fr) Appareil respiratoire
SE437329B (sv) Sett att ur blodserum framstella vaccin mot virushepatit
FR2322593A1 (fr) Nouveaux analogues de prostaglandines et medicament les contenant
IT1101376B (it) Organo di sgancio con un dispositivo per produrre un'elevata sensibilita' e per stabilizzare la sensibilita' dell'organo di sgancio,preferibilmente organo di sgancio a magnete di tenuta
FI932759A7 (fi) IL-4:n käyttö rokotteiden immunogeeneihin kohdistuvan immuunireaktion lisäämiseksi
FR2297635A1 (fr) Vaccin antigrippal contenant un antigene neuraminidase purifie et application
NZ181498A (en) A live rabies virus and a vaccine there of
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
IT1065702B (it) Dispositivo per la depurazione di gas
IT1062878B (it) Dispositivo di pompaggio adiniezione di combustibile